IP Library Granted Patent US 9,693,792
Granted Patent B2
US 9,693,792 · App. 11/582,746 · Granted Jul 4, 2017

Ultrasonic treatment method and apparatus with active pain suppression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,693,792
App. No.
11/582,746
Granted
Jul 4, 2017
Kind
B2
Abstract

An ultrasonic medical treatment device has a probe, a transducer for mechanically vibrating the probe at an ultrasonic frequency, a voltage source for energizing the transducer, and another electrical voltage source for feeding to the probe a high-frequency alternating waveform of limited current and limited voltage to be conducted into a patient through the operative tip of the probe after placement of the operative tip into contact with the patient. The alternating waveform has a current and a voltage so limited as to prevent damage to organic tissues while stimulating nerves to reduce or suppress pain.

Claims (17)

1. A medical treatment device comprising:

an ultrasonic probe;

a transducer assembly operatively connected to said probe for mechanically vibrating said probe so that an operative tip of said probe oscillates at an ultrasonic frequency;

a first electrical voltage source operatively connected to said transducer assembly for energizing same with an alternating voltage having an ultrasonic frequency;

a second electrical voltage source operatively connected to said probe for feeding thereto a high-frequency alternating waveform of limited current and limited voltage to be conducted into a patient through said operative tip of said probe after placement of said operative tip into contact with the patient, said alternating waveform having a current and a voltage so limited as to prevent damage to organic tissues while stimulating nerves to reduce or suppress pain; and

a synchronization circuit operatively connected to at least one of said first electrical voltage source and said second electrical voltage source and having an enabling circuit component including a time delay element for enabling a commencing of probe vibration only after a predetermined time period has elapsed after a conducting of said alternating waveform into the patient has commenced.

2. The medical treatment device defined in claim 1 wherein said enabling circuit component further includes a detector operatively connected to said delay element, said detector being operatively connected to at least one of said probe and said second electrical voltage source for sensing when a conducting of said alternating waveform into the patient via said probe has commenced.

3. The medical treatment device defined in claim 1 wherein said second electrical voltage source is configured to provide said alternating waveform with a frequency between approximately 70 MHz and approximately 100 MHz.

4. The medical treatment device defined in claim 1 wherein said second electrical voltage source includes a circuit for pulsing said alternating waveform.

5. A medical treatment method comprising:

contacting a patient with an operative tip of an ultrasonic probe;

conducting a high-frequency alternating voltage into the patient through said operative tip of said probe while said operative tip is in contact with the patient, said alternating voltage having a current and a voltage so limited as to prevent damage to organic tissues while stimulating nerves to reduce or suppress pain; and

mechanically vibrating said probe so that said operative tip oscillates at an ultrasonic frequency while said operative tip is in contact with the patient,

the mechanical vibrating of said probe commencing only after a predetermined time period has elapsed after a conducting of said alternating waveform into the patient has commenced.

6. The medical treatment method defined in claim 5 wherein the enabling includes automatically detecting when a conducting of said alternating voltage into the patient via said probe has commenced.

7. The medical treatment method defined in claim 5 wherein said alternating voltage has a frequency between approximately 70 MHz and 100 MHz.

8. The medical treatment method defined in claim 5 wherein the conducting of said alternating voltage includes pulsing said alternating voltage.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Aug 4, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: MISONIX OPCO, LLC
Reel/Frame 072338/0395 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MISONIX, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 072298/0866 →
MERGER AND CHANGE OF NAME Recorded Nov 29, 2022
From: MISONIX INCORPORATED; OYSTER MERGER SUB II, LLC
To: MISONIX, LLC
Reel/Frame 061906/0564 →
MERGER AND CHANGE OF NAME Recorded Sep 14, 2022
From: OYSTER OPCO MERGER SUB, LLC; MISONIX OPCO, INC.
To: MISONIX OPCO, LLC
Reel/Frame 061433/0736 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: SWK FUNDING, LLC, AS COLLATERAL AGENT
To: MISONIX OPCO, INC.
Reel/Frame 060220/0792 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: SILICON VALLEY BANK
To: MISONIX OPCO, INC.
Reel/Frame 060220/0773 →
SECURITY INTEREST Recorded Nov 11, 2021
From: MISONIX OPCO, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058809/0950 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 16, 2020
From: MISONIX OPCO, INC.
To: SWK FUNDING LLC
Reel/Frame 052167/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 30, 2019
From: MISONIX OPCO, INC.
To: SILICON VALLEY BANK
Reel/Frame 051447/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2006
From: NOVAK, THEODORE A. D.; MANNA, RONALD R.
To: MISONIX, INCORPORATED
Reel/Frame 018437/0180 →